
CCRN
Cross Country Healthcare Inc
- Overview
- Forecast
- Valuation

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
14.800
Open
13.960
VWAP
14.02
Vol
157.90K
Mkt Cap
458.64M
Low
13.940
Amount
2.21M
EV/EBITDA(TTM)
30.52
Total Shares
34.77M
EV
391.53M
EV/OCF(TTM)
3.27
P/S(TTM)
0.36
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. It operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs (MSP); education healthcare services; in-home care services; and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, government facilities and managed care organizations.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
305.86M
-1.32%
0.111
+178.58%
298.04M
-5.42%
0.089
-26.19%
295.18M
-13.12%
0.074
-25.71%
Estimates Revision
The market is revising Downward the revenue expectations for Cross Country Healthcare, Inc. (CCRN) for FY2025, with the revenue forecasts being adjusted by -11.52% over the past three months. During the same period, the stock price has changed by -22.58%.
Revenue Estimates for FY2025
Revise Downward

-11.52%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-41.56%
In Past 3 Month
Stock Price
Go Down

-22.58%
In Past 3 Month
7 Analyst Rating

33.02% Upside
Wall Street analysts forecast CCRN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCRN is 18.61 USD with a low forecast of 18.61 USD and a high forecast of 18.61 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
7 Hold
0 Sell
Hold

33.02% Upside
Current: 13.990

Low
18.61
Averages
18.61
High
18.61

33.02% Upside
Current: 13.990

Low
18.61
Averages
18.61
High
18.61
UBS
A.J. Rice
Hold
Maintains
$19 → $17
2025-05-13
New
Reason
UBS
A.J. Rice
Price Target
$19 → $17
2025-05-13
New
Maintains
Hold
Reason
Barrington Research
Kevin Steinke
Hold
Maintains
$19
2025-03-14
Reason
Barrington Research
Kevin Steinke
Price Target
$19
2025-03-14
Maintains
Hold
Reason
JMP Securities
Constantine Davides
Hold
Reiterates
n/a
2025-02-06
Reason
JMP Securities
Constantine Davides
Price Target
n/a
2025-02-06
Reiterates
Hold
Reason
Barrington Research
Kevin Steinke
Buy
to
Hold
Downgrades
n/a
2024-12-10
Reason
Barrington Research
Kevin Steinke
Price Target
n/a
2024-12-10
Downgrades
Buy
to
Hold
Reason
Truist Securities
Tobey Sommer
Hold
Maintains
$15 → $19
2024-12-05
Reason
Truist Securities
Tobey Sommer
Price Target
$15 → $19
2024-12-05
Maintains
Hold
Reason
Benchmark
Bill Sutherland
Strong Buy
Maintains
$19 → $18
2024-11-07
Reason
Benchmark
Bill Sutherland
Price Target
$19 → $18
2024-11-07
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Cross Country Healthcare Inc (CCRN.O) is 38.90, compared to its 5-year average forward P/E of 51.76. For a more detailed relative valuation and DCF analysis to assess Cross Country Healthcare Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
51.76
Current PE
38.90
Overvalued PE
236.52
Undervalued PE
-133.01
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
7.93
Current EV/EBITDA
8.99
Overvalued EV/EBITDA
11.29
Undervalued EV/EBITDA
4.58
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
0.41
Current PS
0.38
Overvalued PS
0.51
Undervalued PS
0.31
Financials
Annual
Quarterly
FY2025Q1
YoY :
-22.62%
293.41M
Total Revenue
FY2025Q1
YoY :
-83.18%
1.37M
Operating Profit
FY2025Q1
YoY :
-118.20%
-490.00K
Net Income after Tax
FY2025Q1
YoY :
-125.00%
-0.02
EPS - Diluted
FY2025Q1
YoY :
-0.16%
3.80M
Free Cash Flow
FY2025Q1
YoY :
-4.12%
18.37
Gross Profit Margin - %
FY2025Q1
YoY :
-19.47%
8.85
FCF Margin - %
FY2025Q1
YoY :
-123.94%
-0.17
Net Margin - %
FY2025Q1
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
1.0M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CCRN News & Events
Events Timeline
2025-05-07 (ET)
2025-05-07
16:26:07
Cross Country Healthcare reports Q1 adjusted EPS 6c, consensus 7c

2025-03-05 (ET)
2025-03-05
16:19:04
Cross Country Healthcare reports Q4 adjusted EPS 4c, consensus 11c

2025-02-28 (ET)
2025-02-28
16:48:44
Cross Country Healthcare stockholders approve Aya Healthcare transaction

Sign Up For More Events
Sign Up For More Events
News
8.0
04-29NewsfilterNursing in 2025: No Relief in Sight as Burnout, Stress & Short Staffing Persist
4.0
04-01NASDAQ.COMValidea Benjamin Graham Strategy Daily Upgrade Report - 4/22/2025
4.0
03-10Business InsiderAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Trevi Therapeutics (TRVI) and Cross Country Healthcare (CCRN)
Sign Up For More News
People Also Watch

CMP
Compass Minerals International Inc
19.180
USD
-1.64%

CGEM
Cullinan Oncology Inc
7.500
USD
+3.59%

CTO
CTO Realty Growth Inc
18.430
USD
+0.77%

UPB
Upstream Bio Inc
8.640
USD
-1.59%

KRT
Karat Packaging Inc
31.270
USD
+2.46%

CTLP
Cantaloupe Inc
8.490
USD
+0.71%

DNTH
Dianthus Therapeutics Inc
19.690
USD
+5.01%

ZJK
ZJK Industrial Co Ltd
4.700
USD
+3.07%

WEST
Westrock Coffee Co
7.840
USD
+5.23%

AUTL
Autolus Therapeutics PLC
1.330
USD
+3.10%
FAQ

What is Cross Country Healthcare Inc (CCRN) stock price today?
The current price of CCRN is 13.99 USD — it has increased 0.29 % in the last trading day.

What is Cross Country Healthcare Inc (CCRN)'s business?

What is the price predicton of CCRN Stock?

What is Cross Country Healthcare Inc (CCRN)'s revenue for the last quarter?

What is Cross Country Healthcare Inc (CCRN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Cross Country Healthcare Inc (CCRN)'s fundamentals?

How many employees does Cross Country Healthcare Inc (CCRN). have?
